scholarly journals Functional assessment using short tests in a patient with Pompe disease receiving enzyme replacement therapy: case report

Case reports ◽  
2019 ◽  
Vol 5 (2) ◽  
pp. 98-104
Author(s):  
Thomas Torres-Cuenca ◽  
Jorge Arturo Díaz-Ruíz ◽  
Fernando Ortiz-Corredor

Introduction: Pompe disease is characterized by the deficiency of the acid alfa glucosidase enzyme, which leads to a glycogen accumu­lation mainly in cardiac and skeletal muscles. Its onset may be early or late; the late form is more difficult to handle given the variety of presenta­tions. Enzyme replacement therapy has shown to improve gross motor function and lung function in patients.Case description: Female patient who presented chronic quadriparesis. She was diagnosed with Pompe disease, which required enzyme replace­ment therapy that helped improve the symptoms, which was evident with the performance of rapid functional evaluation tests.Discussion: Enzyme replacement therapy in Pompe disease modifies the natural history of the disease. A brief review of the literature about the functional tests that can be used to assess a patient with this disorder is presented.Conclusion: The 10-meter walk test, one-leg stance test, cervical flexion in supine position, five times sit to stand test, and coin rotation task are useful for clinical evaluation in patients with Pompe disease receiving enzyme replacement therapy.

2018 ◽  
Vol 13 (1) ◽  
Author(s):  
Rossella Parini ◽  
Paola De Lorenzo ◽  
Andrea Dardis ◽  
Alberto Burlina ◽  
Alessandra Cassio ◽  
...  

2020 ◽  
Vol 7 (11) ◽  
pp. 2246
Author(s):  
Abhishek K. Phadke ◽  
Ali Kumble ◽  
Yusuf Kumble ◽  
Sapheliya Nazar

Glycogen storage disease type II, also called Pompe disease or acid maltase deficiency is a disorder of muscle glycogenoses with a wide range of clinical manifestations. It is one of the disorders of glycogen metabolism caused by a deficiency of lysosomal acid α-1, 4-glucosidase (acid maltase) resulting in lysosomal glycogen accumulation in cardiac, skeletal and smooth muscle cells. The pattern of inheritance is autosomal recessive with a gene for enzyme located on chromosome 17q25.2.It is the first recognized lysosomal storage disorder and the first neuromuscular disorder for which enzyme replacement therapy has been approved. We report a case of four month old female child, born to primi gravida third degree consanguineous couple, who presented with history of respiratory illness, hypotonia and developmental delay. Baby was sick needing mechanical ventilation and inotropic support. Echocardiography showed concentric LV hypertrophy with no LV outflow tract obstruction. In view of consanguinity, developmental delay, hepatomegaly and cardiomegaly, provisional diagnosis of a storage disorder, probably infantile Pompe disease was considered. Dried blood spot for α-1, 4-glucosidase enzyme assay confirmed the same. Enzyme replacement therapy was considered, but child progressed to cardiac failure needing prolonged ventilation and expired on day 8 of admission. Whole genome exome sequencing revealed 2 mutations which confirmed the diagnosis. Infantile Pompe disease is fatal without treatment. High index of suspicion and early diagnosis may help in taking advantage of emerging therapeutics, such as ERT which is capable of changing the natural history of the disease.


2005 ◽  
Vol 36 (02) ◽  
Author(s):  
M Smitka ◽  
M von der Hagen ◽  
A Kaindl ◽  
C Gilitzer ◽  
J Dumontier ◽  
...  

2018 ◽  
Vol 123 (2) ◽  
pp. S124-S125
Author(s):  
Roberto Sandobal Pacheco ◽  
Diana Espinosa Villanueva ◽  
Adriana Alcnatara Salinas ◽  
Jorge A. Romero Ramirez ◽  
Jose Antonio Vasquez Galeana ◽  
...  

2012 ◽  
Vol 44 (5) ◽  
pp. 771-775 ◽  
Author(s):  
MAURO MARZORATI ◽  
SIMONE PORCELLI ◽  
BARBARA REGGIORI ◽  
LUCIA MORANDI ◽  
BRUNO GRASSI

2006 ◽  
Vol 8 (5) ◽  
pp. 297-301 ◽  
Author(s):  
Annette K Ansong ◽  
Jennifer S Li ◽  
Eva Nozik-Grayck ◽  
Richard Ing ◽  
Richard M Kravitz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document